Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy.

ABSTRACT: Pediatric high-grade glioma (pHGG) is the leading cause of cancer death in children. Despite histologic similarities, it has recently become apparent that this disease is molecularly distinct from its adult counterpart. Specific hallmark oncogenic histone mutations within pediatric malignant gliomas divide these tumors into subgroups with different neuroanatomic and chronologic predilections. In this review, we will summarize the characteristic molecular alterations of pediatric high-grade gliomas, with a focus on how preclinical models of these alterations have furthered our understanding of their oncogenicity as well as their potential impact on developing targeted therapies for this devastating disease.

SUBMITTER: Graham MS 

PROVIDER: S-EPMC7582376 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature